Definitive Clinical Oncology, Cellular Pathology & Genomic Biomarkers.
This regional capacity analysis evaluates Bavarian general practitioners' perspectives on managing post-treatment cancer survivors within decentralized healthcare structures. The findings outline infrastructural gaps, communication...
Biomimetic scaffold-based three-dimensional (3D) models replicate the biophysical and biochemical complexity of the tumor microenvironment to study oncogenesis. These advanced physiological culture platforms bridge...
Glioblastoma is the most malignant primary brain tumor in adults, characterized by diffuse cerebral infiltration and profound therapeutic resistance. Novel aptamer-based drug delivery systems...
Epitope generation gateways dictate the efficacy of neoantigen-specific cancer vaccines by controlling intracellular antigen processing, peptide loading, and major histocompatibility complex presentation. Understanding context-dependent...
Pembrolizumab combined with disitamab vedotin represents an emerging precision immunotherapeutic and antibody-drug conjugate strategy for HER2-positive, treatment-refractory metastatic colorectal cancer. This regimen targets tumor-associated...
Evaluation of nivolumab efficacy in advanced solid tumors defined by high blood tumor mutational burden via circulating tumor DNA profiling. This biomarker strategy expands...
Non-small cell lung carcinoma encompasses a heterogeneous group of malignancies driven by specific genomic alterations requiring precision targeted therapies. Comprehensive molecular profiling guides first-line...
Nucleotide excision repair orchestrates the recognition and elimination of bulky DNA helix-distorting adducts induced by platinum-based chemotherapies and UV radiation. Dysregulation of this critical...
Immunotherapy consolidation following concurrent chemoradiotherapy establishes a standard paradigm for locally advanced esophageal cancer. Immune checkpoint inhibition mitigates radiation-induced adaptive immunosuppression, significantly prolonging progression-free...
Advanced endometrial carcinoma is defined by molecular heterogeneity requiring integration of epigenetic profiling and immune checkpoint inhibition. Recent clinical paradigms highlight the synergistic efficacy...
Chimeric antigen receptor (CAR)-T cell therapy has revolutionized refractory hematologic malignancy management through genetically redirected lymphocyte cytotoxicity. This treatise details functional receptor architecture, vector...